Replies to post #9994 on Decision Diagnostics Corp (DECN)

[Leirum]

Again, I think you really missed all.

We are talking about;



Due Diligence Information:

FDA 510(K) Clearance Letter:
http://www.pharmatechdirect.com/genstripletter.html

Company Press Release on GenStrip Opportunities from Changes in Industry:
http://finance.yahoo.com/news/decn-steps-role-white-knight-131500330.html

Forbes Article on DECN, March 2013:
http://www.forbes.com/sites/genemarcial/2013/03/11/jj-faces-potentially-disrupting-competition-in-its-lucrative-glucose-monitoring-business-from-tiny-diagnostics-outfit/?partner=yahootix

Diabetes Mine Article, December 2012:
http://www.diabetesmine.com/2012/12/new-generic-test-strips-may-be-better-than-originals.html

Article on Prospects of DECN, December 2012:
http://finance.yahoo.com/news/opportunity-market-decision-diagnostics-otcbb-165538562.html

Interview with the CEO, November 2012:
http://finance.yahoo.com/news/q-medical-technology-stock-decision-171445923.html


•
Diabetes: J&J loses a round in glucose testing battle with Shasta (Nov 7)

•
Decision Diagnostics On Track For Growth And Increased Revenues (Nov 7)

•
DECN And Pharma Tech Solutions Receive Anticipated Ruling From The U.S. Federal Circuit Court Of Appeals, Reversing A Ruling By Lower Court Judge (Nov 5)

•
DECN Wins Only Case That Matters in Federal Circuit Court (.pdf) (Nov 4)